Paraskevi V Voulgari Selected Research

Necrosis

3/2022	Anti-Rheumatic Drugs May Ameliorate the Clinical Course and Outcome of COVID-19 In Rheumatoid Arthritis Patients.
11/2020	Adalimumab-induced myasthenia gravis: case-based review.
6/2020	Clinical, Serological and Immunological Characteristics in Greek Patients with Psoriatic Arthritis: The Role of IL-17, IL-23, and Sclerostin.
1/2019	Clinical evaluation of the safety, efficacy and tolerability of sarilumab in the treatment of moderate to severe rheumatoid arthritis.
1/2018	ABP 501 for the treatment of rheumatoid arthritis.
7/2015	Golimumab, the newest TNF-α blocker, comes of age.
10/2009	Effects of a 6-month infliximab treatment on plasma levels of leptin and adiponectin in patients with rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paraskevi V Voulgari Research Topics

Disease

45	Rheumatoid Arthritis 05/2024 - 02/2002
15	Ankylosing Spondylitis 01/2024 - 08/2007
13	Psoriatic Arthritis 01/2023 - 02/2007
9	COVID-19 12/2023 - 09/2020
8	Arthritis (Polyarthritis) 01/2024 - 01/2011
8	Rheumatic Diseases (Rheumatism) 12/2023 - 01/2009
7	Necrosis 03/2022 - 10/2009
6	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2024 - 02/2007
6	Infections 01/2024 - 02/2014
6	Spondylarthropathies 01/2024 - 06/2011
5	Autoimmune Diseases (Autoimmune Disease) 06/2023 - 07/2012
4	Pain (Aches) 01/2024 - 08/2019
4	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 10/2015
4	Hypertension (High Blood Pressure) 01/2022 - 06/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 01/2020
3	Thrombocytopenia (Thrombopenia) 12/2022 - 12/2003
3	Disease Progression 03/2022 - 01/2009
3	Schizophrenia (Dementia Praecox) 01/2022 - 10/2015
3	Inflammation (Inflammations) 12/2021 - 07/2013
3	Leukopenia 03/2021 - 12/2003
3	Lymphoma (Lymphomas) 01/2021 - 01/2020
3	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2019 - 01/2009
3	Body Weight (Weight, Body) 04/2011 - 07/2010
2	Wounds and Injuries (Trauma) 01/2024 - 06/2014
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2024 - 01/2014
2	Joint Diseases (Joint Disease) 01/2024 - 01/2018
2	Hypercholesterolemia 01/2023 - 11/2020
2	Lupus Nephritis 01/2023 - 08/2012
2	Cytokine Release Syndrome 01/2022 - 09/2020
2	Anemia 12/2021 - 12/2003
2	Fever (Fevers) 03/2021 - 08/2013
2	Arthralgia (Joint Pain) 01/2021 - 08/2013
2	Dyslipidemias (Dyslipidemia) 08/2020 - 06/2014
2	Obesity 03/2019 - 01/2014
2	Giant Cell Arteritis (Horton Disease) 01/2019 - 06/2018
2	Insulin Resistance 12/2016 - 07/2013
2	Diabetes Mellitus 06/2014 - 10/2009
2	Demyelinating Diseases (Demyelinating Disease) 06/2014 - 01/2014
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2013 - 10/2008
2	Crohn Disease (Crohn's Disease) 12/2012 - 01/2011
2	Synovitis 02/2006 - 12/2005
1	Localized Scleroderma (Morphea) 01/2024
1	Connective Tissue Diseases (Connective Tissue Disease) 12/2023
1	scedosporiosis 06/2023
1	Hypertriglyceridemia 01/2023
1	Neutropenia 12/2022

Drug/Important Bio-Agent (IBA)

18	Infliximab (Remicade)FDA Link 03/2019 - 05/2005
16	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 01/2006
15	Adalimumab (Humira)FDA Link 01/2024 - 02/2006
12	Antirheumatic Agents (DMARD)IBA 04/2022 - 02/2002
10	Methotrexate (Mexate)FDA LinkGeneric 01/2024 - 01/2006
9	CytokinesIBA 01/2024 - 10/2015
5	Tumor Necrosis Factor InhibitorsIBA 01/2024 - 12/2017
5	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2024 - 08/2013
5	Interleukin-6 (Interleukin 6)IBA 06/2023 - 10/2015
5	LipidsIBA 01/2023 - 08/2008
5	AntibodiesIBA 12/2022 - 01/2011
5	Etanercept (Enbrel)FDA Link 01/2021 - 04/2011
5	Monoclonal AntibodiesIBA 11/2020 - 01/2009
4	Biosimilar PharmaceuticalsIBA 01/2024 - 01/2021
4	Colchicine FDA LinkGeneric 01/2024 - 01/2021
4	Interleukin-17 (Interleukin 17)IBA 03/2022 - 10/2015
4	Acute-Phase Proteins (Acute-Phase Protein)IBA 03/2022 - 01/2021
4	C-Reactive ProteinIBA 12/2021 - 03/2003
4	InterleukinsIBA 12/2020 - 10/2015
4	golimumab FDA Link 03/2019 - 09/2010
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024 - 01/2011
3	AutoantibodiesIBA 01/2022 - 01/2020
3	Prednisone (Sone)FDA LinkGeneric 01/2022 - 01/2019
3	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 11/2020
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2024 - 12/2020
2	GlucocorticoidsIBA 01/2024 - 02/2014
2	VaccinesIBA 12/2023 - 01/2022
2	SteroidsIBA 06/2023 - 09/2015
2	Ferritins (Ferritin)IBA 03/2022 - 12/2021
2	Janus KinasesIBA 01/2022 - 12/2020
2	AdiponectinIBA 01/2022 - 10/2009
2	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 10/2017
2	LeptinIBA 01/2022 - 10/2009
2	Interleukin-2 (IL2)IBA 10/2017 - 10/2015
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 09/2014 - 06/2011
1	Bispecific AntibodiesIBA 05/2024
1	YttriumIBA 01/2024
1	Calcium PyrophosphateIBA 01/2024
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2024
1	Rituximab (Mabthera)FDA Link 12/2023
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 12/2023
1	Immunomodulating AgentsIBA 06/2023
1	Itraconazole (Sporanox)FDA LinkGeneric 06/2023
1	Voriconazole (Vfend)FDA LinkGeneric 06/2023
1	molnupiravirIBA 01/2023
1	apremilastIBA 01/2023
1	oxidized low density lipoproteinIBA 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	nirmatrelvir and ritonavir drug combinationIBA 01/2023
1	Triglycerides (Triacylglycerol)IBA 01/2023
1	InflammasomesIBA 04/2022

Therapy/Procedure

22	Therapeutics 05/2024 - 05/2005
3	Biological Therapy 12/2023 - 01/2021
1	Intra-Articular Injections 01/2024